Biocon Takes Its Oncology Biosimilars To 30 Countries In Africa And Asia

Enables Access To Trastuzumab And Pegfilgrastim Through Cancer Access Partnership

 
• By Akriti Seth
  
CHAI
Biocon plans to launch oncology biosimilars in 25 African countries and five Asian countries • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products